Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma. - Wikidata - awgldk - TriplyDB

Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.

Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.

http://www.wikidata.org/entity/Q38402754

about

Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series.Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification.Expression Level of Genes Coding for Cell Adhesion Molecules of Cadherin Group in Colorectal Cancer Patients.Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients Differential expression of E-cadherin, β-catenin, and S100A4 in intestinal type and nonintestinal type ampulla of Vater cancers.Gene of the month: E-cadherin (CDH1).Relation of glypican-3 and E-cadherin expressions to clinicopathological features and prognosis of mucinous and non-mucinous colorectal adenocarcinoma.DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer.Overexpression of 14-3-3ζ in lung tissue predicts an improved outcome in patients with lung adenocarcinoma.

P2860

Q33659798-0038A98C-E32A-437F-BADB-FFC14BFC1FE0 Q35619098-AC7F27D7-1269-4AE3-8FE1-F0CFA4D845FA Q35887522-F4DFE945-D8C6-4D6A-B2AA-EEE4528D6345 Q37057045-FEF532E4-58EA-49B2-AFF4-E56D8749936B Q37564069-AE24C8A9-FFEE-4956-82C4-67FD86A7D950 Q38128549-326A4A67-BE41-40C0-90EF-672864F778D9 Q41529909-09CED613-3AE2-44D4-AAA1-8035E836F1A8 Q47141452-CD0F49BA-324C-4098-97AF-5F9B69E7A834 Q55512817-E7A595EF-20C1-4C7E-8EB2-926606D2B6DE

P2860

Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.

http://www.wikidata.org/entity/Q38402754

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Loss of E-cadherin expression ...... vival in colorectal carcinoma.

@en

type

label

Loss of E-cadherin expression ...... vival in colorectal carcinoma.

@en

prefLabel

Loss of E-cadherin expression ...... vival in colorectal carcinoma.

@en

P1433

Q38402754-ED987A8F-F8A3-4088-9DEE-05C9D73803CF

P1476

Q38402754-B28A821F-B99B-4AB5-BF7E-FD1F3DFC5C63

P2093

Q38402754-0C0EA12A-E612-4383-9249-77AD7EE9F172

Q38402754-843A117C-E4A5-4684-BAE6-1BB90236019D

Q38402754-8BACA70F-8445-47DB-826B-AF50159B1A45

Q38402754-B68D4FAC-344B-4E14-8BD5-F65966A0FBDE

Q38402754-D06A7C2F-6021-4DC1-AE47-FA82B6450D43

Q38402754-E368D62E-49EF-4FE8-8AEC-73DCD35644BA

Q38402754-FBF0384A-AE54-47B4-AD46-D30177D4CAF5

P2860

Q38402754-024F5002-44E4-4A66-9660-8708056DFEE6

Q38402754-0B7A99C0-BE6A-456B-8CB3-E3B265FFF8B3

Q38402754-10222C17-6E3F-43B6-BB40-0E40E6224576

Q38402754-121BAACB-4348-4369-BC5C-89041DAD7CAA

Q38402754-1558F320-9059-47A0-97BB-4C382B563F2C

Q38402754-17937E6E-ADF3-4554-A122-7F80E2C17138

Q38402754-1BF62725-D3CF-4241-99BB-7650CD4F7439

Q38402754-215E88F0-887F-484D-95E4-EDC78618EC8D

Q38402754-2CCF6753-B9F7-4B17-A804-687F774239C0

Q38402754-2F45A4DD-9B3E-4308-817F-F2DED503DF38

P304

Q38402754-6E0AFD77-D83C-4DE5-A952-2DDB058C1C06

P31

Q38402754-648EBDD0-DF6B-45E4-A0B1-12A70CEDE1AD

P356

Q38402754-FB3CD0DA-E17F-4698-BF79-897930C18E26

P433

Q38402754-577112A0-6DE4-426D-A04A-7F5AC40E2379

P478

Q38402754-B45E53F4-81BC-480D-9F1D-A607681BA055

P577

Q38402754-1611B358-880F-48E0-9686-CD851C3CD2EE

P698

Q38402754-A014B075-B0F9-4B97-83AF-8B3088509FE5

P356

J.1600-0463.2011.02863.X

P1433

Acta Pathologica et Microbiologica Scandinavica

P1476

Loss of E-cadherin expression ...... vival in colorectal carcinoma.

@en

P2093

Abdelbaset Buhmeida

http://www.w3.org/2001/XMLSchema#string

Adam Elzagheid

http://www.w3.org/2001/XMLSchema#string

Kari Syrjänen

http://www.w3.org/2001/XMLSchema#string

Matti Laato

http://www.w3.org/2001/XMLSchema#string

Omran El-Faitori

http://www.w3.org/2001/XMLSchema#string

Seppo Pyrhönen

http://www.w3.org/2001/XMLSchema#string

Yrjö Collan

http://www.w3.org/2001/XMLSchema#string

P2860

Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma.

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer.

E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome

Involvement of members of the cadherin superfamily in cancer

Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value

Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer.

Defective E-cadherin/catenin complexes in human cancer.

P304

539-548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0463.2011.02863.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22716209

http://www.w3.org/2001/XMLSchema#string